Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-6,921
Closed -$349K 218
2016
Q2
$349K Sell
6,921
-4,137
-37% -$209K 0.29% 120
2016
Q1
$535K Sell
11,058
-255
-2% -$9.84K 0.32% 20
2015
Q4
$445K Sell
11,313
-254
-2% -$10.2K 0.27% 110
2015
Q3
$439K Buy
+11,567
New +$488K 0.24% 166

Other funds holding AMED

Lucus Advisors's AMED Position: Q3 2016 in Review

Lucus Advisors sold out of Amedisys (AMED) in Q3 2016, closing a stake of 6,921 shares — an estimated $349K sold.

Lucus Advisors first reported a position in AMED in Q3 2015 and held it in 4 quarters. The position peaked at $535K in Q1 2016. 153 funds tracked by Wall St. Rank hold AMED as of Q3 2016.

  • Lucus Advisors reported no remaining Amedisys position as of Q3 2016 after selling out during the quarter.
  • Lucus Advisors sold 6,921 Amedisys shares in Q3 2016, an estimated $349K.
  • Lucus Advisors first reported a position in Amedisys in Q3 2015 and held it in 4 quarters.
  • Lucus Advisors's Amedisys position peaked at $535K in Q1 2016.
  • 153 funds tracked by Wall St. Rank held Amedisys as of Q3 2016.

Based on Lucus Advisors's 13F filing for Q3 2016, filed 4 Nov 2016.